EPISODE · Aug 29, 2025 · 14 MIN
Managing Side Effects of New Treatments for Small Cell Lung Cancer
from Oncology Brothers: Practice-Changing Cancer Discussions · host Oncology Brothers
Welcome back to the Oncology Brothers podcast! In this episode, we continue the three-part CME series on small cell lung cancer, focusing on adverse events and management strategies for extensive stage small cell lung cancer treatments.We are thrilled to have Dr. Misty Shields from the Indiana University join us to discuss the latest advancements in treatment options following the exciting data presented at ASCO 2025. We dived into the treatment algorithm for patients with good performance status, including the use of chemoimmunotherapy, lurbinectedin, and tarlatamab.Key topics covered in this episode:• Overview of the current treatment landscape and new data from ASCO 2025• Common side effects associated with lurbinectedin and immunotherapy• Strategies for managing adverse events, including hematologic toxicities and liver function monitoring• The role of supportive care and palliative care in enhancing patient quality of life• Collaboration between community oncologists and academic centers for optimal patient careJoin us as we explore the challenges and opportunities in managing extensive stage small cell lung cancer, and learn how to provide the best care for patients facing this devastating disease.Accreditation/Credit DesignationPhysicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Acknowledgment of Commercial SupportThis activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.Link to gain CME credits from this activity:https://www.gotoper.com/courses/practical-considerations-and-future-directions-for-new-treatment-strategies-in-sclcFollow us on social media:• X/Twitter: https://twitter.com/oncbrothers• Instagram: https://www.instagram.com/oncbrothers• Website: https://oncbrothers.com/
What this episode covers
Welcome back to the Oncology Brothers podcast! In this episode, we continue the three-part CME series on small cell lung cancer, focusing on adverse events and management strategies for extensive stage small cell lung cancer treatments.We are thrilled to have Dr. Misty Shields from the Indiana University join us to discuss the latest advancements in treatment options following the exciting data presented at ASCO 2025. We dived into the treatment algorithm for patients with good performance status, including the use of chemoimmunotherapy, lurbinectedin, and tarlatamab.Key topics covered in this episode:• Overview of the current treatment landscape and new data from ASCO 2025• Common side effects associated with lurbinectedin and immunotherapy• Strategies for managing adverse events, including hematologic toxicities and liver function monitoring• The role of supportive care and palliative care in enhancing patient quality of life• Collaboration between community oncologists and academic centers for optimal patient careJoin us as we explore the challenges and opportunities in managing extensive stage small cell lung cancer, and learn how to provide the best care for patients facing this devastating disease.Accreditation/Credit DesignationPhysicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Acknowledgment of Commercial SupportThis activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.Link to gain CME credits from this activity:https://www.gotoper.com/courses/practical-considerations-and-future-directions-for-new-treatment-strategies-in-sclcFollow us on social media:• X/Twitter: https://twitter.com/oncbrothers• Instagram: https://www.instagram.com/oncbrothers• Website: https://oncbrothers.com/
NOW PLAYING
Managing Side Effects of New Treatments for Small Cell Lung Cancer
No transcript for this episode yet
Similar Episodes
Mar 31, 2026 ·54m
Mar 27, 2026 ·14m
Mar 24, 2026 ·42m
Mar 20, 2026 ·42m
Mar 17, 2026 ·41m
Mar 13, 2026 ·44m